跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,010 条关于
“Norgine Pharmaceuticals”
全部
9,010
临床试验
601
药物
1,748
机构
2,056
资讯
4,605
去年
Mavorixafor Advances in Europe for WHIM Syndrome Treatment Following Positive Phase 3 Results
10个月前
Fennec Pharmaceuticals Announces Public Offering to Fund Debt Reduction and Operations
去年
NICE Recommends Pedmarqsi as First NHS Treatment for Cisplatin-Induced Hearing Loss in Children
去年
Norgine Expands Rare Disease Portfolio with Strategic Acquisition of Theravia
7个月前
European Regulators Recommend Approval of First WHIM Syndrome Treatment
9个月前
PEDMARK Shows Significant Reduction in Cisplatin-Induced Hearing Loss in Japanese Pediatric Cancer Study
2年前
Norgine Seeks Approval for Eflornithine in High-Risk Neuroblastoma via Project Orbis
去年
Norgine Seeks EMA Approval for Eflornithine in High-Risk Neuroblastoma
9个月前
Vir Biotechnology Secures €550 Million Licensing Deal with Norgine for Hepatitis Delta Combination Therapy
5个月前
Norgine Receives Swiss Approval for PEDMARQSI, First Treatment to Prevent Cisplatin-Induced Hearing Loss in Children
第 1 页,共 461 页
上一页
下一页